Modern Diagnostic IPO Listing Gain: GMP vs Actual Price, Profit Analysis
Latest Grey Market Premium & IPO Details
Modern Diagnostic IPO 2026 – Key Info & Highlights
Modern Diagnostic IPO 2025 listed with a strong gain of ₹99.50 per share. The IPO delivered positive returns to retail investors, with GMP trends largely matching the actual listing performance.
📌 IPO Details
| Company Name | Modern Diagnostic IPO |
|---|---|
| Sector / Industry | Healthcare / Diagnostic Services |
| IPO Open Date | 31-12-2025 |
| IPO Close Date | 02-01-2026 |
| Allotment Date | 05-01-2026 |
| Refund Date | 06-01-2026 |
| Share Credit Date | 06-01-2026 |
| Listing Date | 07-01-2026 |
| Price Band | ₹85 - ₹90 |
| Lot Size | 1600 Shares |
| Min Investment | ₹2,88,000 (2 lot Value) |
| Total Issue Size | ₹36.89 Cr |
| Reserved for Market Maker | ₹1.86 Cr |
| Net Issue Size | ₹35.04 Cr |
| Fresh Issue | ₹35.04 Cr |
| OFS | ₹Nil Cr |
| IPO Listing At | BSE SME |
| DRHP | View DRHP |
| Issue Type | Book Build Issue |
| Face Value | ₹10 Per Equity Share |
| Promoter Holding Pre IPO | 99.99 % |
| Promoter Holding Post IPO | 72.85% |
* All Dates are provisional
Quota Allocation
| Category | Allocation (%) |
|---|---|
| Retail Investors | 33.26% |
| QIB (Qualified Institutional Buyers) | 47.42% |
| HNI (High Net Worth Individuals) | 14.29% |
📈 Grey Market Premium (GMP) Day-wise Trend
| GMP Date | GMP Price | Trend | Estimated Listing Price | Estimated Profit* | Last Updated |
|---|---|---|---|---|---|
| 06-01-2026 | ₹13.50 | ▼ | ₹103.50 | ₹21600.00 | 06-01-2026 23:35 |
| 05-01-2026 | ₹13.50 | ▼ | ₹103.50 | ₹21600.00 | 05-01-2026 23:43 |
| 04-01-2026 | ₹16.00 | - | ₹106.00 | ₹25600.00 | 04-01-2026 13:57 |
📝 About Modern Diagnostic
Modern Diagnostic & Research Centre Limited is a trusted diagnostic services provider in India with over 30 years of experience. The company offers a wide range of pathology and radiology tests using advanced medical equipment and serves patients, hospitals, and corporate clients across 7 states through its network of diagnostic centres.
The company is launching an SME IPO in the healthcare diagnostics sector, which will open on 31 December 2025 and close on 2 January 2026. Through this IPO, Modern Diagnostic aims to raise approximately ₹36.89 crore via a fresh issue of 40,99,200 equity shares with a lot size of 1,600 shares.
The funds raised will be used for upgrading diagnostic infrastructure, meeting working capital requirements, reducing existing borrowings, and supporting business expansion. The shares are proposed to be listed on the BSE SME platform.
Modern Diagnostic Revised Financials
Profit / Loss & Total Assets (Last 3 Years)
| Financial Year | Revenue (₹ Cr) | Profit / Loss (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| FY 2022 | 60.21 | -1.45 | 48.70 |
| FY 2023 | 56.28 | -5.73 | 36.54 |
| FY 2024 | 67.13 | 5.79 | 49.48 |
Note: Positive figures indicate profit, while negative figures indicate loss. Total Assets are reported in ₹ Cr.
Modern Diagnostic Objects of Issue
- Investment in Advanced Diagnostic Infrastructure – To upgrade and procure modern medical, laboratory, and imaging equipment to enhance diagnostic capabilities.
- Support for Operational & Working Capital Needs – To fund routine business operations and ensure smooth day-to-day functioning.
- Reduction of Existing Financial Liabilities – To repay or prepay outstanding loans and strengthen the company’s balance sheet.
- Strengthening & Expansion of Diagnostic Network – To develop and expand diagnostic centres and improve healthcare service reach.
- General Business & Strategic Requirements – To meet general corporate expenses and support long-term growth initiatives.
Modern Diagnostic IPO Strengths
- Comprehensive Diagnostic Services – The company offers a wide range of pathology, radiology, and advanced diagnostic services under one roof.
- Modern Technology and Equipment – Use of advanced machines and digital reporting systems helps ensure accurate and timely test results.
- Skilled and Experienced Team – A trained team of doctors, technicians, and support staff maintains high standards of diagnostic quality.
- Rising Demand for Healthcare Testing – Increasing awareness of preventive healthcare is driving steady growth in diagnostic services.
- Strong Focus on Quality and Patient Care – The company emphasizes reliable reports, quick turnaround time, and patient satisfaction.
Modern Diagnostic IPO Risks
- High Competition in the Diagnostic Industry – The diagnostic services market is highly competitive, which may affect pricing and margins.
- Dependence on Medical Professionals – The business relies on qualified doctors and technicians, and any shortage or attrition may impact operations.
- Regulatory and Compliance Risk – Healthcare and diagnostic services are subject to strict regulations, and any non-compliance could lead to penalties or operational restrictions.
- High Cost of Medical Equipment – Diagnostic machines require significant capital investment and regular maintenance, which may impact profitability.
- Operational and Technology Risk – Equipment breakdowns, system failures, or delays in reporting may affect service quality and customer trust.
Modern Diagnostic & Research Centre Ltd.
| Founded in: | 2012 |
|---|---|
| MD/CEO: | Mr. Devendra Singh Yadav |
| Address: | Plot No H-64,1st Floor BLK-H, Bali Nagar City landmark near Khetar Pal Hospital, Ramesh Nagar, West Delhi West Delhi, New Delhi-110015 |
| Website: | http://www.mdrcindia.com/ |
| Phone: | 9999474297 |
| Email: | compliance@mdrcindia.com |
| Services: |
|
IPO Quick Info
31 Dec 2025
02 Jan 2026
Upcoming
Related IPOs
- Bagmane REIT
- Recode Studios
- OnEMI Technology
- Value 360 Communications
- Amba Auto Sales & Services
- Adisoft Technologies
- Leapfrog Engineering
- Citius Transnet InvIT
- Mehul Telecom
- Om Power Transmission
- Propshare Celestia
- Safety Controls
- Emiac Technologies
- Vivid Electromech
- Highness Microelectronics
- Sai Parenterals Limited
- Powerica Limited
- Speciality Medicines
- Tipco Engineering
- Amir Chand Jagdish Kumar
Frequently Asked Questions
Modern Diagnostic IPO is offered within a fixed price band, and retail investors need to apply for at least one lot as per the minimum investment requirement.